CHA Biotech Co. Ltd (085660) — Capital Reinvestment Ratio
Latest as of June 2024:
2.52x
CHA Biotech Co. Ltd (085660) has a Capital Reinvestment Ratio of 2.52x as of June 2024, meaning it reinvests 3% of its operating cash flow (₩13.77 Billion) in capital expenditures (₩34.71 Billion). See 085660 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.52x
Capex / Operating Cash Flow
Operating Cash Flow
₩13.77 Billion
KRW
Capital Expenditures
₩34.71 Billion
KRW
Data as of
Jun 2024
Most recent filing
CHA Biotech Co. Ltd Capital Reinvestment Ratio (2009–2023)
This chart tracks CHA Biotech Co. Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for CHA Biotech Co. Ltd (2009–2023)
Year-by-year Capital Reinvestment Ratio for CHA Biotech Co. Ltd from 2009 to 2023. For live market cap and broader valuation context, see CHA Biotech Co. Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 6.46x | ₩11.51 Billion | ₩74.38 Billion | ▲ +24.4% |
| 2021 | 5.19x | ₩22.23 Billion | ₩115.46 Billion | ▲ +93.4% |
| 2020 | 2.69x | ₩47.00 Billion | ₩126.23 Billion | ▼ -37.1% |
| 2019 | 4.27x | ₩25.24 Billion | ₩107.77 Billion | ▲ +311.9% |
| 2018 | 1.04x | ₩75.38 Billion | ₩78.14 Billion | ▼ -66.3% |
| 2017 | 3.07x | ₩12.01 Billion | ₩36.91 Billion | ▲ +1.7% |
| 2016 | 3.02x | ₩11.29 Billion | ₩34.13 Billion | ▲ +496.2% |
| 2015 | 0.51x | ₩61.86 Billion | ₩31.36 Billion | ▲ +20.8% |
| 2013 | 0.42x | ₩66.35 Billion | ₩27.85 Billion | ▼ -37.7% |
| 2012 | 0.67x | ₩45.77 Billion | ₩30.84 Billion | ▼ -8.2% |
| 2011 | 0.73x | ₩34.69 Billion | ₩25.48 Billion | ▲ +22.5% |
| 2010 | 0.60x | ₩42.07 Billion | ₩25.22 Billion | ▼ -19.7% |
| 2009 | 0.75x | ₩24.02 Billion | ₩17.93 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow